These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25529394)

  • 21. [One year follow-up of patients with bullous pemphigoid].
    Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
    Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repigmentation of the white hair after systemic corticosteroids for bullous pemphigoid.
    Khaled A; Trojjets S; Zeglaoui F; Fazaa B; Kamoun MR
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1018-20. PubMed ID: 18081750
    [No Abstract]   [Full Text] [Related]  

  • 23. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate for bullous pemphigoid: preliminary study.
    Bara C; Maillard H; Briand N; Celerier P
    Arch Dermatol; 2003 Nov; 139(11):1506-7. PubMed ID: 14623719
    [No Abstract]   [Full Text] [Related]  

  • 25. Blistering rash in an older man.
    Ward NJ; MacVane CZ
    J Fam Pract; 2013 Mar; 62(3):151-3. PubMed ID: 23520587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dermatologic care of bullous pemphigoid].
    Delacotte A
    Soins; 1982 Nov; (393):29-32. PubMed ID: 6760407
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients.
    Polansky M; Eisenstadt R; DeGrazia T; Zhao X; Liu Y; Feldman R
    J Am Acad Dermatol; 2019 Jul; 81(1):179-186. PubMed ID: 30923002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete remission after rituximab therapy in an HIV-positive patient with pemphigus vulgaris.
    Polansky M; Patel N; Feldman R
    Br J Dermatol; 2015 Dec; 173(6):1557-9. PubMed ID: 26122850
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-laminin γ1 pemphigoid.
    Kalkoff EC; Bramsiepe I; Groth S; Marsch WC; Kreft B
    J Dtsch Dermatol Ges; 2013 Jun; 11(6):555-7. PubMed ID: 23480370
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful management of severe infant bullous pemphigoid with omalizumab.
    Dufour C; Souillet AL; Chaneliere C; Jouen F; Bodemer C; Jullien D; Cambazard F; Joly P; Reix P
    Br J Dermatol; 2012 May; 166(5):1140-2. PubMed ID: 22098309
    [No Abstract]   [Full Text] [Related]  

  • 32. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
    Teraki Y; Hotta T; Shiohara T
    J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study.
    Cortés B; Khelifa E; Clivaz L; Cazzaniga S; Saurat JH; Naldi L; Borradori L
    Dermatology; 2012; 225(4):320-5. PubMed ID: 23257934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bullous pemphigoid in an infant using complementary medicine.
    Purvis DJ; Bhogal BS; Harper JI
    Clin Exp Dermatol; 2009 Mar; 34(2):195-8. PubMed ID: 19187301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
    Wang TS; Tsai TF
    Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of bullous pemphigoid with omalizumab.
    London VA; Kim GH; Fairley JA; Woodley DT
    Arch Dermatol; 2012 Nov; 148(11):1241-3. PubMed ID: 23165827
    [No Abstract]   [Full Text] [Related]  

  • 37. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
    Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
    Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
    Honl BA; Elston DM
    Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
    Nguyen T; Ahmed AR
    Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.